Strategic Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,673
| Closed | -$251K | – | 142 |
|
|
2024
Q3 | $251K | Buy |
8,673
+195
| +2% | +$5.69K | 0.01% | 123 |
|
|
2024
Q2 | $237K | Sell |
8,478
-6,547
| -44% | -$180K | 0.02% | 120 |
|
|
2024
Q1 | $417K | Sell |
15,025
-2,333
| -13% | -$64.7K | 0.03% | 93 |
|
|
2023
Q4 | $500K | Sell |
17,358
-2,478
| -12% | -$74.9K | 0.04% | 87 |
|
|
2023
Q3 | $658K | Sell |
19,836
-1,993
| -9% | -$70.5K | 0.05% | 74 |
|
|
2023
Q2 | $782K | Sell |
21,829
-134
| -0.6% | -$5.22K | 0.06% | 74 |
|
|
2023
Q1 | $896K | Sell |
21,963
-27,021
| -55% | -$1.17M | 0.07% | 66 |
|
|
2022
Q4 | $2.51M | Sell |
48,984
-1,779
| -4% | -$85.3K | 0.2% | 42 |
|
|
2022
Q3 | $2.22M | Sell |
50,763
-1,269
| -2% | -$61.7K | 0.2% | 46 |
|
|
2022
Q2 | $2.73M | Sell |
52,032
-11,007
| -17% | -$561K | 0.23% | 41 |
|
|
2022
Q1 | $3.26M | Buy |
63,039
+4,945
| +9% | +$257K | 0.25% | 41 |
|
|
2021
Q4 | $3.43M | Sell |
58,094
-864
| -1% | -$42.8K | 0.26% | 44 |
|
|
2021
Q3 | $2.54M | Sell |
58,958
-1,559
| -3% | -$69.1K | 0.2% | 53 |
|
|
2021
Q2 | $2.37M | Sell |
60,517
-530
| -0.9% | -$20.6K | 0.19% | 60 |
|
|
2021
Q1 | $2.21M | Sell |
61,047
-6,090
| -9% | -$216K | 0.19% | 62 |
|
|
2020
Q4 | $2.47M | Sell |
67,137
-4,362
| -6% | -$160K | 0.22% | 61 |
|
|
2020
Q3 | $2.49M | Sell |
71,499
-2,257
| -3% | -$79.1K | 0.26% | 54 |
|
|
2020
Q2 | $2.29M | Sell |
73,756
-29,536
| -29% | -$1M | 0.25% | 57 |
|
|
2020
Q1 | $3.2M | Sell |
103,292
-15,022
| -13% | -$512K | 0.43% | 46 |
|
|
2019
Q4 | $4.4M | Sell |
118,314
-24,285
| -17% | -$865K | 0.51% | 52 |
|
|
2019
Q3 | $4.86M | Sell |
142,599
-2,946
| -2% | -$107K | 0.62% | 49 |
|
|
2019
Q2 | $5.98M | Sell |
145,545
-1,970
| -1% | -$78.2K | 0.79% | 32 |
|
|
2019
Q1 | $5.94M | Sell |
147,515
-1,796
| -1% | -$71.9K | 0.82% | 32 |
|
|
2018
Q4 | $6.18M | Buy |
149,311
+13,232
| +10% | +$549K | 0.97% | 26 |
|
|
2018
Q3 | $5.69M | Sell |
136,079
-4,147
| -3% | -$160K | 0.85% | 24 |
|
|
2018
Q2 | $4.83M | Sell |
140,226
-838
| -0.6% | -$28.6K | 0.74% | 32 |
|
|
2018
Q1 | $4.75M | Buy |
141,064
+479
| +0.3% | +$16.5K | 0.77% | 28 |
|
|
2017
Q4 | $4.83M | Sell |
140,585
-307
| -0.2% | -$10.5K | 0.76% | 29 |
|
|
2017
Q3 | $4.77M | Sell |
140,892
-1,467
| -1% | -$47.1K | 0.79% | 28 |
|
|
2017
Q2 | $4.54M | Buy |
142,359
+504
| +0.4% | +$15.9K | 0.79% | 29 |
|
|
2017
Q1 | $4.6M | Buy |
141,855
+320
| +0.2% | +$10.1K | 0.84% | 25 |
|
|
2016
Q4 | $4.36M | Buy |
141,535
+2,149
| +2% | +$65.6K | 0.84% | 25 |
|
|
2016
Q3 | $4.48M | Sell |
139,386
-13,460
| -9% | -$450K | 0.89% | 20 |
|
|
2016
Q2 | $5.35M | Sell |
152,846
-1,448
| -0.9% | -$46.2K | 1.07% | 12 |
|
|
2016
Q1 | $4.34M | Buy |
154,294
+6,748
| +5% | +$193K | 1.01% | 17 |
|
|
2015
Q4 | $4.52M | Buy |
147,546
+3,222
| +2% | +$101K | 1.19% | 18 |
|
|
2015
Q3 | $4.3M | Buy |
144,324
+3,884
| +3% | +$125K | 1.19% | 17 |
|
|
2015
Q2 | $4.47M | Sell |
140,440
-1,839
| -1% | -$59.9K | 1.25% | 15 |
|
|
2015
Q1 | $4.7M | Buy |
142,279
+13,868
| +11% | +$441K | 1.21% | 17 |
|
|
2014
Q4 | $3.79M | Buy |
128,411
+1,594
| +1% | +$45.7K | 1.03% | 32 |
|
|
2014
Q3 | $3.56M | Buy |
126,817
+2,461
| +2% | +$69.1K | 0.99% | 31 |
|
|
2014
Q2 | $3.5M | Buy |
124,356
+29,591
| +31% | +$844K | 0.97% | 32 |
|
|
2014
Q1 | $2.89M | Buy |
94,765
+4,732
| +5% | +$141K | 0.85% | 50 |
|
|
2013
Q4 | $2.62M | Sell |
90,033
-8,812
| -9% | -$256K | 0.83% | 55 |
|
|
2013
Q3 | $2.69M | Buy |
98,845
+5,539
| +6% | +$151K | 0.91% | 37 |
|
|
2013
Q2 | $2.48M | Buy |
+93,306
| New | +$2.58M | 0.88% | 45 |
|
Other funds holding PFE
Strategic Financial Services's PFE Position: Q4 2024 in Review
Strategic Financial Services sold out of Pfizer (PFE) in Q4 2024, closing a stake of 8,673 shares — an estimated $251K sold.
Strategic Financial Services first reported a position in PFE in Q2 2013 and held it in 46 quarters. The position peaked at $6.18M in Q4 2018. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Strategic Financial Services reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- Strategic Financial Services sold 8,673 Pfizer shares in Q4 2024, an estimated $251K.
- Strategic Financial Services first reported a position in Pfizer in Q2 2013 and held it in 46 quarters.
- Strategic Financial Services's Pfizer position peaked at $6.18M in Q4 2018.
- 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Strategic Financial Services's 13F filing for Q4 2024, filed 11 Feb 2025.